Novel COL11A2 Pathogenic Variants in a Child with Autosomal Recessive Otospondylomegaepiphyseal Dysplasia: A Review of the Literature

Abstract

Otospondylomegaepiphyseal dysplasia (OSMED) is an inherited autosomal dominant and recessive skeletal dysplasia caused by both heterozygous and homozygous pathogenic variants in COL11A2 encoding the α2(XI) collagen chains, a part of type XI collagen. Here, we describe a 2-year-old girl presenting from birth with a phenotype suggestive of OSMED. On whole exome sequence analysis of the family via commercially available methods, we detected two novel heterozygous pathogenic variants in the proband. In addition, we reviewed the phenotype of autosomal recessive OSMED cases with COL11A2 pathogenic variants reported to date and quantitatively highlighted the phenotypic spectrum.

Keywords

otospondylomegaepiphyseal dysplasia - autosomal recessive - COL11A2

Note

ClinVar accession numbers are as follows:

Variant 1: c.339_340delCCinsG, p.Leu114Trpfs*31 (accession number: SCV000590729.2).

Variant 2: c.190 C > T, p.Arg64* (accession number: SCV000590451.3).

• References

• 1 Vikkula M, Mariman EC, Lui VC. , et al. Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus. Cell 1995; 80 (03) 431-437
• 2 Melkoniemi M, Brunner HG, Manouvrier S. , et al. Autosomal recessive disorder otospondylomegaepiphyseal dysplasia is associated with loss-of-function mutations in the COL11A2 gene. Am J Hum Genet 2000; 66 (02) 368-377
• 3 Temtamy SA, Männikkö M, Abdel-Salam GMH, Hassan NA, Ala-Kokko L, Afifi HH. Oto-spondylo-megaepiphyseal dysplasia (OSMED): clinical and radiological findings in sibs homozygous for premature stop codon mutation in the COL11A2 gene. Am J Med Genet A 2006; 140 (11) 1189-1195
• 4 Brown MR, Tomek MS, Van Laer L. , et al. A novel locus for autosomal dominant nonsyndromic hearing loss, DFNA13, maps to chromosome 6p. Am J Hum Genet 1997; 61 (04) 924-927
• 5 Chen W, Kahrizi K, Meyer NC. , et al. Mutation of COL11A2 causes autosomal recessive non-syndromic hearing loss at the DFNB53 locus. J Med Genet 2005; 42 (10) e61
• 6 Tompson SW, Faqeih EA, Ala-Kokko L. , et al. Dominant and recessive forms of fibrochondrogenesis resulting from mutations at a second locus, COL11A2 . Am J Med Genet A 2012; 158A [phone]
• 7 Burgeson RE, Hollister DW. Collagen heterogeneity in human cartilage: identification of several new collagen chains. Biochem Biophys Res Commun 1979; 87 (04) 1124-1131
• 8 Blaschke UK, Eikenberry EF, Hulmes DJ, Galla HJ, Bruckner P. Collagen XI nucleates self-assembly and limits lateral growth of cartilage fibrils. J Biol Chem 2000; 275 (14) 10370-10378
• 9 Gregory KE, Oxford JT, Chen Y. , et al. Structural organization of distinct domains within the non-collagenous N-terminal region of collagen type XI. J Biol Chem 2000; 275 (15) 11498-11506
• 10 Luo Y. Biochemistry of collagens, laminins and elastin: structure, function and biomarkers. In: Biochemistry of Collagens, 1st ed. Amsterdam: Elsevier Ltd. Academic Press; 2016: 77-80
• 11 Vuoristo MM, Pappas JG, Jansen V, Ala-Kokko L. A stop codon mutation in COL11A2 induces exon skipping and leads to non-ocular Stickler syndrome. Am J Med Genet A 2004; 130A [phone]
• 12 Snead MP, Yates JR. Clinical and molecular genetics of Stickler syndrome. J Med Genet 1999; 36 (05) 353-359
• 13 Wilkin DJ, Artz AS, South S. , et al. Small deletions in the type II collagen triple helix produce kniest dysplasia. Am J Med Genet 1999; 85 (02) 105-112
• 14 Harel T, Rabinowitz R, Hendler N. , et al. COL11A2 mutation associated with autosomal recessive Weissenbacher-Zweymuller syndrome: molecular and clinical overlap with otospondylomegaepiphyseal dysplasia (OSMED). Am J Med Genet A 2005; 132A (01) 33-35
• 15 Rabinowitz R, Gradstein L, Galil A, Levy J, Lifshitz T. The ocular manifestations of Weissenbacher-Zweymuller syndrome. Eye (Lond) 2004; 18 (12) 1258-1263
• 16 Sirko-Osadsa DA, Murray MA, Scott JA, Lavery MA, Warman ML, Robin NH. Stickler syndrome without eye involvement is caused by mutations in COL11A2, the gene encoding the alpha2(XI) chain of type XI collagen. J Pediatr 1998; 132 (02) 368-371
• 17 van Steensel MA, Buma P, de Waal Malefijt MC, van den Hoogen FH, Brunner HG. Oto- spondylo-megaepiphyseal dysplasia (OSMED): clinical description of three patients homozygous for a missense mutation in the COL11A2 gene. Am J Med Genet 1997; 70 (03) 315-323
• 18 Richards S, Aziz N, Bale S. , et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
• 19 Kayserili H, Wollnik B, Güven G, Emiroğlu MU, Başerer N, Uyguner ZO. A novel homozygous COL11A2 deletion causes a C-terminal protein truncation with incomplete mRNA decay in a Turkish patient. Am J Med Genet A 2011; 155A [phone]
• 20 Tokgöz-Yılmaz S, Sahlı S, Fitoz S, Sennaroğlu G, Tekin M. Audiological findings in otospondylomegaepiphyseal dysplasia (OSMED) associated with a novel mutation in COL11A2 . Int J Pediatr Otorhinolaryngol 2011; 75 (03) 433-437
• 21 Ren J, Wen L, Gao X, Jin C, Xue Y, Yao X. DOG 1.0: illustrator of protein domain structures. Cell Res 2009; 19 (02) 271-273